Download PDF

Price: $0
No charge, funded by The Conference Board of Canada and/or the research sponsor

Health Care Aware: Understanding Pharmaceutical Pricing in Canada

The Conference Board of Canada, 43 pages, October 4, 2018
Briefing by , ,
5.0/5 based on 2 reviews
(You must be signed in and entitled to rate this report)
This briefing explores the inputs and costs that are reflected in the final retail cost of pharmaceuticals, sheds light on how pharmacy markups are determined, and discusses key themes and opportunities.

Document Highlights

The retail price of pharmaceuticals is a result of different costs, markups, and fees, few of which are well understood by consumers. The final retail cost of the same drug can vary across provinces and territories, and within jurisdictions, prompting concerns and complaints about fairness. Perhaps the least understood cost component is the pharmacy markup. Pharmacy markups appear to vary across several factors, including location, type of drug, the pharmacy, and whether public or private insurance is involved.

Drawing on information and insights gathered from a literature review and interviews with key stakeholders, this briefing explores the inputs and costs that are reflected in the final retail cost of pharmaceuticals, sheds light on how pharmacy markups are determined, and discusses key themes and opportunities. It is the first in the new Health Care Aware series, which aims to bring greater transparency on a number of complex issues in health care.

Download PDF

Price: $0
No charge, funded by The Conference Board of Canada and/or the research sponsor